A Novel Preoperative Prediction Model Based on Deep Learning to Predict Neoplasm T Staging and Grading in Patients with Upper Tract Urothelial Carcinoma.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: Deep-learning models predicted pathological T stage and grade from preoperative data in 884 upper-tract urothelial carcinoma patients. A random 80/20 patient split assessed selected CNN-BiGRU/BiGRU models; AUCs ranged 0.760–0.824 across endpoints. This is a retrospective single-center diagnostic-prediction result.
Technology: Five deep-learning architectures compared; XGBoost screening and clinical feature selection preceded model fitting. Random train/test split 80/20; 884 pathologically confirmed patients. Best T-stage CNN-BiGRU AUC 0.760; grade AUC 0.804 (1973 WHO) and 0.824 (2004 WHO).
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Five deep-learning architectures compared; XGBoost screening and clinical feature selection preceded model fitting. Random train/test split 80/20; 884 pathologically confirmed patients. Best T-stage CNN-BiGRU AUC 0.760; grade AUC 0.804 (1973 WHO) and 0.824 (2004 WHO).
- Limitation / still unknown
- Results are limited to the reported models, cohorts, datasets or experiments; broader generalization and clinical or operational benefit were not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://mdpi-res.com/d_attachment/jcm/jcm-11-05815/article_deploy/jcm-11-05815.pdf
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.